Shanghai Model Organisms Center, Inc. (SHA:688265)

China · Delayed Price · Currency is CNY

41.30

+0.39 (0.95%)

At close: Mar 30, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Custom Model		33.91M			38.11M	42.48M	-	-
Custom Model Growth		-			-10.28%	-	-	-
Standardized Model		164.77M			94.91M	53.44M	-	-
Standardized Model Growth		-			77.59%	-	-	-
Model Breeding		90.06M			74.85M	56.82M	-	-
Model Breeding Growth		-			31.72%	-	-	-
Drug Efficacy Evaluation and Phenotypic Analysis		53.20M			38.15M	18.08M	-	-
Drug Efficacy Evaluation and Phenotypic Analysis Growth		-			111.06%	-	-	-
Feeding Service		29.97M			24.98M	22.40M	-	-
Feeding Service Growth		-			11.51%	-	-	-
Other Model Biotechnology Services		6.58M			2.63M	2.34M	-	-
Other Model Biotechnology Services Growth		-			12.56%	-	-	-
Biotechnology		-			-	-	154.80M	121.44M
Biotechnology Growth		-			-	-	27.47%	-
Total		378.49M			273.64M	195.56M	154.80M	121.44M
Total Growth		-			39.92%	26.33%	27.47%	59.83%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
China		325.43M			-	-	154.80M	121.44M
China Growth		-			-	-	27.47%	63.97%
Overseas		53.06M			-	-	-	-
Total		378.49M			-	-	154.80M	121.44M
Total Growth		-			-	-	27.47%	59.83%

Source: S&P Global Market Intelligence.